<?xml version="1.0" encoding="UTF-8"?>
<ref id="b38-1040797">
 <label>38.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Benjamini</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Jain</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Trinh</surname>
    <given-names>L</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes</article-title>. 
  <source>Leuk Lymphoma</source>. 
  <year>2015</year>;
  <volume>56</volume>(
  <issue>6</issue>):
  <fpage>1643</fpage>â€“
  <lpage>1650</lpage>.
  <pub-id pub-id-type="pmid">25308294</pub-id>
 </mixed-citation>
</ref>
